Jonathan P. Schneck Institute for Cell Engineering, School of Medicine Johns Hopkins University Biography Publications Institution JoVE Articles Jonathan P. Schneck has not added a biography. If you are Jonathan P. Schneck and would like to personalize this page please email our Author Liaison for assistance. Publications Efficient Magnetic Enrichment of Antigen-specific T Cells by Engineering Particle Properties Biomaterials. Dec, 2018 | Pubmed ID: 30312851 Engineering Platforms for T Cell Modulation International Review of Cell and Molecular Biology. 2018 | Pubmed ID: 30262034 ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis Cancer Immunology Research. 02, 2018 | Pubmed ID: 29263161 Tumor and Microenvironment Evolution During Immunotherapy with Nivolumab Cell. Nov, 2017 | Pubmed ID: 29033130 Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation Nano Letters. 11, 2017 | Pubmed ID: 28994285 Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth ACS Nano. 06, 2017 | Pubmed ID: 28589725 Cytotoxic Polyfunctionality Maturation of Cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell Responses in Older Adults Positively Correlates with Response Size Scientific Reports. Jan, 2016 | Pubmed ID: 26778409 Linking Form to Function: Biophysical Aspects of Artificial Antigen Presenting Cell Design Biochimica Et Biophysica Acta. Apr, 2015 | Pubmed ID: 25200637 Magnetic Field-induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity ACS Nano. Mar, 2014 | Pubmed ID: 24564881 Sprouty-2 Regulates HIV-specific T Cell Polyfunctionality The Journal of Clinical Investigation. Jan, 2014 | Pubmed ID: 24292711 Particle Shape Dependence of CD8+ T Cell Activation by Artificial Antigen Presenting Cells Biomaterials. Jan, 2014 | Pubmed ID: 24099710 Nanoscale Artificial Antigen Presenting Cells for T Cell Immunotherapy Nanomedicine : Nanotechnology, Biology, and Medicine. Jan, 2014 | Pubmed ID: 23891987 T-cell Memory Responses Elicited by Yellow Fever Vaccine Are Targeted to Overlapping Epitopes Containing Multiple HLA-I and -II Binding Motifs PLoS Neglected Tropical Diseases. 2013 | Pubmed ID: 23383350 Identificazione Molecolare Di GD3 Come Soppressore Della Risposta Immunitaria Innata Nel Carcinoma Ovarico Cancer Research. Aug, 2012 | Pubmed ID: 22649190 Fluorescenza Di Quantum Dot Caratterizza L'organizzazione Su Scala Nanometrica Dei Recettori Delle Cellule T Per L'antigene Biophysical Journal. Dec, 2011 | Pubmed ID: 22261075 Declino Del Repertorio Di Cellule CD8 + T Specifici Per L'influenza in Donatori Sani Geriatrici Immunity & Ageing : I & A. 2011 | Pubmed ID: 21846352 Inibizione Del Ligando Di Fas in Topi NOD Smaschera Un Ruolo Protettivo Per IL-10 Contro Lo Sviluppo Insulitis The American Journal of Pathology. Aug, 2011 | Pubmed ID: 21718680 High-throughput Lectina Microarray-based Analysis of Glycosylation Superficie Cellulare Dal Vivo Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [et Al.]. Feb, 2011 | Pubmed ID: 21400689 Killer Cellule Presentanti L'antigene Artificiale: L'incarnazione Di Un 'missile Guidato' Sintetico Immunotherapy. Jul, 2010 | Pubmed ID: 20636007 Regolamento Dinamico Delle Cellule Di T Funzionalmente Distinte Virus-specifici Proceedings of the National Academy of Sciences of the United States of America. Feb, 2010 | Pubmed ID: 20133680 Panoramica Di Un HLA-Ig "Lego-come Sistema" Per La Cellula T, Modulazione E L'espansione Di Monitoraggio Basato Su Immunologic Research. Jul, 2010 | Pubmed ID: 20087680 Somministrazione in Vivo Di Cellule Presentanti L'antigene Artificiale Attiva Le Cellule T Bassa Avidità Per Il Trattamento Del Cancro Cancer Research. Dec, 2009 | Pubmed ID: 19934317 Polisaccaride Capsulare Di Streptococcus Pneumoniae Serotype 1 Induce I Linfociti T Regolatori CD8CD28 TCR Reticolazione PLoS Pathogens. Sep, 2009 | Pubmed ID: 19779562 Sviluppo Di Un Test Artificiale-antigene-presentare-cell-based Per La Rilevazione Di Bassa Frequenza Virus-specifiche Cellule T Cellule Nel Sangue Intero, Con Applicazione Per Virus Del Morbillo Clinical and Vaccine Immunology : CVI. Jul, 2009 | Pubmed ID: 19494085 Ex Vivo Induzione Ed Espansione Delle Cellule Di T Killer Naturale Di CD1d1-Ig Rivestito Artificiale Cellule Presentanti L'antigene Journal of Immunological Methods. Jul, 2009 | Pubmed ID: 19446558 Efficacia Funzionale in Vivo Delle Cellule T Tumorali Specifici Espansa Usando Artificiale Cellule (aAPC) Presentanti L'antigene HLA-Ig Basato Cancer Immunology, Immunotherapy : CII. Feb, 2009 | Pubmed ID: 18563409 Apoptosi FAS-mediata Regola La Composizione Del Periferico Alphabeta Repertorio Delle Cellule T SPURGANDO Costitutivamente Cellule T Double Negative PloS One. 2008 | Pubmed ID: 18941614 Lectina Microarrays Identificare Marcatori Glycan Superficie Cellulare Delle Cellule Specifiche E Funzionalmente Significativa Glycobiology. Oct, 2008 | Pubmed ID: 18625848 Killer Cellule Presentanti L'antigene Artificiale: Una Romanzo Strategia Per Eliminare Cellule T Specifiche Blood. Apr, 2008 | Pubmed ID: 18096763 Protezione Dal Diabete Autoimmune E Cellule T Linfoproliferazione Indotta Dalla Mutazione FasL Differenzialmente Sono Regolati E Può Essere Sganciata Farmacologicamente The American Journal of Pathology. Jul, 2007 | Pubmed ID: 17591957 Un Nanoscopica Plurivalenti Presentanti L'antigene Vettore Per La Consegna Di Droga E Rilevazione Sensibile a Cellule T Nanomedicine : Nanotechnology, Biology, and Medicine. Mar, 2007 | Pubmed ID: 17379171 Rilevamento Delle Cellule T Antigene-specifiche Sui Microarrays P/MHC Journal of Molecular Recognition : JMR. Jan-Feb, 2007 | Pubmed ID: 17094178 GLD Mutazione Del Ligando Di Fas Aumenta La Frequenza E Up-regola Geni Sopravvivenza Delle Cellule CD25 + CD4 + Cellule TR International Immunology. Aug, 2006 | Pubmed ID: 16769751 Valutazione Della Risposta CD8 + T-cell Topoisomerasi-1-specifiche Nella Sclerosi Sistemica Annals of the New York Academy of Sciences. Dec, 2005 | Pubmed ID: 16461796 Dimeri Di Antigene/MHC Classe II/Ig Per Lo Studio Delle Cellule Uveitogenic T: IRBP P161-180 Presentato Da Molecole Di IA E Di IE Investigative Ophthalmology & Visual Science. Oct, 2005 | Pubmed ID: 16186361 Le Cellule Presentanti L'antigene Artificiali: Soluzioni Artificiali Per Reali Malattie Trends in Molecular Medicine. Sep, 2005 | Pubmed ID: 16103011 Progressi Tecnologici in Adoptive Immunoterapia Drugs of Today (Barcelona, Spain : 1998). Jan, 2005 | Pubmed ID: 15753966 Effetto Dell'infezione Umana Di Papillomavirus-16 Su Riconoscimento CD8 + T-cellula Di Un Peptide P53264-272 Sequenza Wild-type in Pazienti Con Carcinoma a Cellule Squamose Della Testa E Del Collo Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2004 | Pubmed ID: 15501971 Qualità E Quantità: Nuove Strategie Per Migliorare L'immunoterapia Del Cancro Trends in Molecular Medicine. May, 2004 | Pubmed ID: 15121045 HLA-Ig-based Artificiale Cellule Presentanti L'antigene: Impostando I Termini Di Impegno Clinical Immunology (Orlando, Fla.). Mar, 2004 | Pubmed ID: 15047202 Le Cellule T Double Negative B220 + Sopprimono Attivazione Policlonale Delle Cellule T Da Un Meccanismo Indipendente Dal Fas Che Coinvolge L'inibizione Della Produzione Di IL-2 Journal of Immunology (Baltimore, Md. : 1950). Sep, 2003 | Pubmed ID: 12928389 Ex Vivo Induzione Ed Espansione Delle Cellule Di T Linfociti Antigene-specifici Di HLA-Ig-coated Artificiale Cellule Presentanti L'antigene Nature Medicine. May, 2003 | Pubmed ID: 12704385 Molecole MHC-peptide-beta2-microglobulina Fusione Legano Le Cellule T Antigene-specifiche E Possono Essere Utilizzati Per I Complessi MHC-Ig Polivalente Journal of Immunological Methods. Dec, 2002 | Pubmed ID: 12445736 Organizzazione Di Membrana Delle Cellule T Sondaggio Utilizzando Dimerica Complessi MHC-Ig Journal of Immunological Methods. Oct, 2002 | Pubmed ID: 12213346 Immunodominance Delle Cellule T E La Manutenzione Della Memoria Regolato Da Agenti Patogeni Inaspettatamente Interferenti Nature Immunology. Jul, 2002 | Pubmed ID: 12055626 Sviluppo E Utilizzo Di Molecole Complesse Di Istocompatibilità Multimerica Clinical and Diagnostic Laboratory Immunology. Mar, 2002 | Pubmed ID: 11874855 Lack of Coreceptor Allows Survival of Chronically Stimulated Double-negative Alpha/beta T Cells: Implications for Autoimmunity The Journal of Experimental Medicine. May, 2001 | Pubmed ID: 11369783 Direct Visualization of Antigen-specific T Cells: HTLV-1 Tax11-19- Specific CD8(+) T Cells Are Activated in Peripheral Blood and Accumulate in Cerebrospinal Fluid from HAM/TSP Patients Proceedings of the National Academy of Sciences of the United States of America. Jun, 1998 | Pubmed ID: 9636190 Analysis of the Expression of Peptide-major Histocompatibility Complexes Using High Affinity Soluble Divalent T Cell Receptors The Journal of Experimental Medicine. Oct, 1997 | Pubmed ID: 9334373 Differential Effects of B Cell Receptor and B Cell Receptor-FcgammaRIIB1 Engagement on Docking of Csk to GTPase-activating Protein (GAP)-associated P62 The Journal of Experimental Medicine. Jul, 1997 | Pubmed ID: 9221755 Arricchire ed espandere cellule T antigene-specifiche rara con nanoparticelle magnetiche John W. Hickey1,2,3,4, Jonathan P. Schneck2,4 1Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, 2Institute for Cell Engineering, School of Medicine, Johns Hopkins University, 3Institute for Nanobiotechnology, Johns Hopkins University, 4Department of Pathology, School of Medicine, Johns Hopkins University JoVE 58640 Engineering Killer artificiale cellule presentanti l'antigene (KaAPC) per una efficiente Christian Schütz1, Martin Fleck2,3, Jonathan P. Schneck1, Mathias Oelke1 1Department of Pathology, Institute of Cell Engineering, Johns Hopkins University, 2Department of Internal Medicine I, University of Regensburg, 3Department of Rheumatology, Asklepios Medical Center JoVE 51859 Immunology and Infection HLA-Ig celle in base Antigen Presenting artificiale per Efficiente Ex vivo Estensione dei diritti dell'uomo e CTL Yen-Ling Chiu1,2, Jonathan P. Schneck3,4, Mathias Oelke3,4 1Immunology Graduate Program, Johns Hopkins University, 2Department of Internal Medicine, Far-Eastern Memorial Hospital, 3Department of Pathology, Johns Hopkins University, 4Institute of Cell Engineering, Johns Hopkins University JoVE 2801 Immunology and Infection
Arricchire ed espandere cellule T antigene-specifiche rara con nanoparticelle magnetiche John W. Hickey1,2,3,4, Jonathan P. Schneck2,4 1Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, 2Institute for Cell Engineering, School of Medicine, Johns Hopkins University, 3Institute for Nanobiotechnology, Johns Hopkins University, 4Department of Pathology, School of Medicine, Johns Hopkins University JoVE 58640 Engineering
Killer artificiale cellule presentanti l'antigene (KaAPC) per una efficiente Christian Schütz1, Martin Fleck2,3, Jonathan P. Schneck1, Mathias Oelke1 1Department of Pathology, Institute of Cell Engineering, Johns Hopkins University, 2Department of Internal Medicine I, University of Regensburg, 3Department of Rheumatology, Asklepios Medical Center JoVE 51859 Immunology and Infection
HLA-Ig celle in base Antigen Presenting artificiale per Efficiente Ex vivo Estensione dei diritti dell'uomo e CTL Yen-Ling Chiu1,2, Jonathan P. Schneck3,4, Mathias Oelke3,4 1Immunology Graduate Program, Johns Hopkins University, 2Department of Internal Medicine, Far-Eastern Memorial Hospital, 3Department of Pathology, Johns Hopkins University, 4Institute of Cell Engineering, Johns Hopkins University JoVE 2801 Immunology and Infection